Literature DB >> 10502613

Chitosan microspheres prepared by spray drying.

P He1, S S Davis, L Illum.   

Abstract

Non-crosslinked and crosslinked chitosan microspheres were prepared by a spray drying method. The microspheres so prepared had a good sphericity and a smooth but distorted surface morphology. They were positively charged. The particle size ranged from 2 to 10 micron. The size and seta potential of the particles were influenced by the crosslinking level. With decreasing amount of crosslinking agent (either glutaraldehyde or formaldehyde), both particle size and zeta potential were increased. Preparation conditions also had some influence on the particle size. DSC studies revealed that the H2 antagonist drug cimetidine, as well as famotidine was molecularly dispersed inside the microspheres, in the form of a solid solution. The release of model drugs (cimetidine, famotidine and nizatidine) from these microspheres was fast, and accompanied by a burst effect.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10502613     DOI: 10.1016/s0378-5173(99)00125-8

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  38 in total

1.  Evaluation of mucoadhesive properties of chitosan microspheres prepared by different methods.

Authors:  Sanju Dhawan; Anil Kumar Singla; Vivek Ranjan Sinha
Journal:  AAPS PharmSciTech       Date:  2004-07-26       Impact factor: 3.246

Review 2.  Pharmaceutical particle engineering via spray drying.

Authors:  Reinhard Vehring
Journal:  Pharm Res       Date:  2007-11-28       Impact factor: 4.200

3.  An approach for lacidipine loaded gastroretentive formulation prepared by different methods for gastroparesis in diabetic patients.

Authors:  Shaheen Sultana; Sushama Talegaonkar; Devender Singh; Riyaz Ahmad; Venu Manukonda; Aseem Bhatnagar; F J Ahmad
Journal:  Saudi Pharm J       Date:  2013-04-17       Impact factor: 4.330

4.  Electrospun chitosan microspheres for complete encapsulation of anionic proteins: controlling particle size and encapsulation efficiency.

Authors:  Ji Suk Choi; Younghee Kim; Jihyun Kang; Seo Young Jeong; Hyuk Sang Yoo
Journal:  AAPS PharmSciTech       Date:  2013-04-30       Impact factor: 3.246

5.  Spray Dried Chitosan Microparticles for Intravesical Delivery of Celecoxib: Preparation and Characterization.

Authors:  Angela Lopedota; Annalisa Cutrignelli; Valentino Laquintana; Nunzio Denora; Rosa Maria Iacobazzi; Mara Perrone; Elisabetta Fanizza; Maria Mastrodonato; Donatella Mentino; Antonio Lopalco; Nicoletta Depalo; Massimo Franco
Journal:  Pharm Res       Date:  2016-05-31       Impact factor: 4.200

6.  Effects of spray drying on physicochemical properties of chitosan acid salts.

Authors:  Mirna Fernández Cervera; Jyrki Heinämäki; Nilia de la Paz; Orestes López; Sirkka Liisa Maunu; Tommi Virtanen; Timo Hatanpää; Osmo Antikainen; Antonio Nogueira; Jorge Fundora; Jouko Yliruusi
Journal:  AAPS PharmSciTech       Date:  2011-05-11       Impact factor: 3.246

7.  Starch-chitosan hydrogels prepared by reductive alkylation cross-linking.

Authors:  E T Baran; J F Mano; R L Reis
Journal:  J Mater Sci Mater Med       Date:  2004-07       Impact factor: 3.896

8.  Chitosan-genipin microspheres for the controlled release of drugs: clarithromycin, tramadol and heparin.

Authors:  Ruth Harris; Elena Lecumberri; Angeles Heras
Journal:  Mar Drugs       Date:  2010-05-26       Impact factor: 5.118

9.  Chemical improvement of chitosan-modified beads for the immobilization of Enterococcus faecium DBFIQ E36 L-arabinose isomerase through multipoint covalent attachment approach.

Authors:  Ricardo M Manzo; Marylane de Sousa; Cecilia L Fenoglio; Luciana Rocha Barro Gonçalves; Enrique J Mammarella
Journal:  J Ind Microbiol Biotechnol       Date:  2015-08-08       Impact factor: 3.346

10.  In vitro and in vivo studies on chitosan beads of losartan Duolite AP143 complex, optimized by using statistical experimental design.

Authors:  Ashwini Madgulkar; Mangesh Bhalekar; Megha Swami
Journal:  AAPS PharmSciTech       Date:  2009-06-03       Impact factor: 3.246

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.